Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

9.34USD
16 Aug 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$9.34
Open
$9.17
Day's High
$9.79
Day's Low
$9.17
Volume
146,552
Avg. Vol
145,172
52-wk High
$24.34
52-wk Low
$8.79

About

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development... (more)

Overall

Beta: 0.59
Market Cap(Mil.): $464.44
Shares Outstanding(Mil.): 45.31
Dividend: --
Yield (%): --

Financials

  CTMX.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.91 -- --
ROI: -25.41 7.52 12.69
ROE: -96.66 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates